Respiratory Disease News and Research

RSS

Trial finds prunes do not outperform calcium and vitamin D for male bone density

A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density in older men susceptible to, or with, osteopenia. Although some bone turnover biomarkers differed between prune and control groups, these changes did not translate into measurable bone density benefits beyond calcium and vitamin D3 supplementation.

11 Jun 2026

Vaping devices and flavors affect genes differently

Vaping exposure affects gene activity in the mouth, with variations linked to device type and flavor, suggesting unique molecular responses compared to smoking.

4 Jun 2026

Lifestyle habits predict long-term health better than cancer treatment history

Healthy lifestyle habits are crucial for childhood cancer survivors, reducing risks of chronic conditions and improving quality of life more than treatments.

2 Jun 2026

Herbal cigarettes are not safer than regular tobacco alternatives

Herbal cigarettes, widely sold in India and abroad as natural, tobacco-free, and even therapeutic alternatives to conventional cigarettes, are not safer than regular tobacco cigarettes.

29 May 2026

Rattlesnakes show higher vulnerability to fungal and parasitic infections

Snakes are threatened with extinction in many places around the globe. Disease, often caused by parasites or fungi, is thought to be one of the key factors alongside habitat destruction.

26 May 2026

Study finds widespread hantavirus exposure among Pacific Northwest rodent populations

The Sin Nombre virus – a hantavirus that can cause a deadly respiratory disease in humans – may be more widespread among rodent populations in parts of the Pacific Northwest than previously recognized.

21 May 2026

Study finds pulmonary rehab empowers children with respiratory issues

New research presented at the 2026 ATS International Conference shows that pulmonary rehabilitation (PR) significantly improves functioning and quality of life in children with chronic respiratory conditions, regardless of whether lung function itself improves.

18 May 2026

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that its Phase 2 trial for ETD001, the Company's lead candidate for treatment of cystic fibrosis (CF), achieved its primary efficacy outcome.

From Enterprise Therapeutics Ltd 12 May 2026

Influenza D shows strong potential to spill over to humans

The influenza D virus that researchers say has been flying under the radar since its detection in animals in 2011 can vigorously make copies of itself in human cells and lung tissue samples, a new study shows.

24 Apr 2026

Gaining weight before age 30 tied to higher mortality

The study reveals that weight gain before 30 years is associated with increased mortality risk, underscoring the need for early obesity intervention strategies.

15 Apr 2026

Lab study shows cigarette smoke damaged lung cells more than e-cigarette vapor

Researchers found that cigarette smoke extract disrupted the lung cell barrier, increased IL-6 inflammation, and caused DNA damage in Calu-3 cells, while e-cigarette vapor extract showed no significant adverse effects on these measures under the study conditions. The authors caution that these were in vitro findings using liquid extracts and unflavored e-liquid, so they do not directly predict long-term human health outcomes.

12 Apr 2026

Salaera™ launches to advance the future of breath and gas technologies

Perma Pure and Maxtec today announced their unification under a new parent company, Salaera, forming a global technology platform dedicated to the integrity of breath and gas systems.

From Salaera™ 7 Apr 2026

What happens when more of your exercise is vigorous instead of moderate?

In a large UK Biobank analysis, a higher proportion of vigorous physical activity relative to total activity volume was associated with lower risks of eight major chronic diseases and all-cause mortality, even after accounting for overall activity volume. Device-based data suggested that activity intensity generally offered greater preventive potential than total volume alone across most outcomes.

31 Mar 2026

Breathing in common disinfectant chemicals may be more harmful than oral ingestion

Breathing in common disinfectant chemicals known as quaternary ammonium compounds, or QACs, may be far more harmful than swallowing them, according to a mouse study led by researchers at the University of California, Davis.

30 Mar 2026

Obesity sharply increases hospitalisation risk from infections, global analysis shows

Adult obesity is associated with a substantially higher risk of severe hospital-treated or fatal infections across multiple pathogens, with risk increasing as obesity severity rises. Global modelling suggests roughly one in ten infection-related deaths worldwide may be attributable to adult obesity, although causality cannot be confirmed.

15 Feb 2026